SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVAS-an interesting california-based biotech company here -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (107)12/3/2002 8:39:21 PM
From: Miljenko Zuanic  Respond to of 126
 
Thanks WE.

This PIa/b trial was part of the IND for PII trial, swing from SC to i.v. bolus dosing. Appears that staff work as coronary anti-clot agent. I am not aware that they are again presenting old staff, EPCI data. Anyway, for comparison check DNA anti-TF-mAb (PRO38747).

Miljenko